MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/cid/civ265

Медицинская библиотека · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2015

Concurrent Anemia and Elevated C-Reactive Protein Predicts HIV Clinical Treatment Failure, Including Tuberculosis, After Antiretroviral Therapy Initiation.

Shivakoti Rupak, Yang Wei-Teng, Gupte Nikhil, Berendes Sima, Rosa Alberto La, Cardoso Sandra W, Mwelase Noluthando, Kanyama Cecilia, Pillay Sandy, Samaneka Wadzanai, Riviere Cynthia, Sugandhavesa Patcharaphan, Santos Brento, Poongulali Selvamuthu, Tripathy Srikanth, Bollinger Robert C, Currier Judith S, Tang Alice M, Semba Richard D, Christian Parul, Campbell Thomas B, Gupta Amita, New Work Concept Sheet 319 and The Prospective Evaluation of Antiretrovirals in Resource-Limited Settings Study Team

СтатьяРандомизированное исследованиеПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Anemia is a known risk factor for clinical failure following antiretroviral therapy (ART). Notably, anemia and inflammation are interrelated, and recent studies have associated elevated C-reactive protein (CRP), an inflammation marker, with adverse human immunodeficiency virus (HIV) treatment outcomes, yet their joint effect is not known. The objective of this study was to assess prevalence and risk factors of anemia in HIV infection and to determine whether anemia and elevated CRP jointly predict clinical failure post-ART.

METHODS

A case-cohort study (N = 470 [236 cases, 234 controls]) was nested within a multinational randomized trial of ART efficacy (Prospective Evaluation of Antiretrovirals in Resource Limited Settings [PEARLS]). Cases were incident World Health Organization stage 3, 4, or death by 96 weeks of ART treatment (clinical failure). Multivariable logistic regression was used to determine risk factors for pre-ART (baseline) anemia (females: hemoglobin <12.0 g/dL; males: hemoglobin <13.0 g/dL). Association of anemia as well as concurrent baseline anemia and inflammation (CRP ≥ 10 mg/L) with clinical failure were assessed using multivariable Cox models.

RESULTS

Baseline anemia prevalence was 51% with 15% prevalence of concurrent anemia and inflammation. In analysis of clinical failure, multivariate-adjusted hazard ratios were 6.41 (95% confidence interval [CI], 2.82-14.57) for concurrent anemia and inflammation, 0.77 (95% CI, .37-1.58) for anemia without inflammation, and 0.45 (95% CI, .11-1.80) for inflammation without anemia compared to those without anemia and inflammation.

CONCLUSIONS

ART-naive, HIV-infected individuals with concurrent anemia and inflammation are at particularly high risk of failing treatment, and understanding the pathogenesis could lead to new interventions. Reducing inflammation and anemia will likely improve HIV disease outcomes. Alternatively, concurrent anemia and inflammation could represent individuals with occult opportunistic infections in need of additional screening.

Для цитирования: Shivakoti Rupak, Yang Wei-Teng, Gupte Nikhil, Berendes Sima, Rosa Alberto La, Cardoso Sandra W, Mwelase Noluthando, Kanyama Cecilia, Pillay Sandy, Samaneka Wadzanai, Riviere Cynthia, Sugandhavesa Patcharaphan, Santos Brento, Poongulali Selvamuthu, Tripathy Srikanth, Bollinger Robert C, Currier Judith S, Tang Alice M, Semba Richard D, Christian Parul, Campbell Thomas B, Gupta Amita, New Work Concept Sheet 319 and The Prospective Evaluation of Antiretrovirals in Resource-Limited Settings Study Team. Concurrent Anemia and Elevated C-Reactive Protein Predicts HIV Clinical Treatment Failure, Including Tuberculosis, After Antiretroviral Therapy Initiation.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2015. DOI: 10.1093/cid/civ265.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.